Risk of Gout in Taiwan Biobank Participants Pertaining to Their Sex and Family History of Gout Among First-degree Relatives

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2023 Sep 5

PMID 37668883

Authors

Hao-Hung Tsai

Disline Manli Tantoh

Chih-Hsuan Hsiao

Ji-Han Zhong

Chih-Yi Chen

Yung-Po Liaw

Affiliations

Soon will be listed here.

Abstract

Background: Family history of gout and sex are independently associated with gout. However, there is a paucity of research regarding the joint role of both factors in gout pathogenesis. Therefore, we assessed the independent and combined association of family history of gout and sex with gout.

Methods: Our analysis included 132,311 Taiwan Biobank (TWB)-enrolled individuals comprising 21,159 gout cases and 111,152 controls. We subcategorized the family history of gout as (1) both siblings and parents had gout), (2) only parents had gout, and (3) only siblings had gout.

Results: Generally, sex (men compared to women) and family history of gout were independently associated with a higher risk of gout. The odds ratio (OR); 95% confidence interval (CI) was 9.175; 8.801-9.566 for sex, and 2.306; 2.206-2.410 for family history. For the subcategories 'both siblings and had gout,' 'only parents had gout,' and 'only siblings had gout,' the odds ratios (ORs); 95% confidence intervals (CIs) were 4.944; 4.414-5.538, 2.041; 1.927-2.161, and 2.162; 2.012-2.323, respectively. The interaction between sex and family history was significant (p value = 0.0001). After stratification by sex, family history of gout remained significantly associated with a higher risk of gout in both sexes, even though the odds ratios were higher in men. For the subcategories 'both siblings and parents had gout,' 'only parent had gout,' and 'only siblings had gout,' the corresponding ORs; 95% CIs were 6.279; 5.243-7.520, 2.211; 2.062-2.371, and 2.148; 1.955-2.361 in men and 4.199; 3.566-4.945, 1.827; 1.640-2.035, and 2.093; 1.876-2.336 in women. After integrating sex and family history (reference: women with no family history), the highest risk of gout was observed in men who had at least one parent and sibling with a history of gout (OR; 95% CI 55.774; 46.360-67.101).

Conclusion: Sex and family history of gout were independently and interactively associated with gout. Sex-wise, men had a higher risk of gout than women. Family history was associated with a higher risk of gout in both sexes, but men had a higher risk. Notably, men having both siblings and parents with gout had the highest risk of gout.

Citing Articles

Risk Factors for Gout in Taiwan Biobank: A Machine Learning Approach.

Liu Y, Nfor O, Zhong J, Lin C, Liaw Y J Inflamm Res. 2024; 17:9847-9856.

PMID: 39618928 PMC: 11608045. DOI: 10.2147/JIR.S490821.

References

Bhole V, De Vera M, Rahman M, Krishnan E, Choi H . Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010; 62(4):1069-76. DOI: 10.1002/art.27338. View

Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M . Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis. 2012; 72(5):694-700. DOI: 10.1136/annrheumdis-2011-201254. View

Singh J, Reddy S, Kundukulam J . Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011; 23(2):192-202. PMC: 4104583. DOI: 10.1097/BOR.0b013e3283438e13. View

Lin K, Lin H, Chou P . The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. 2000; 27(6):1501-5. View

Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E . Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?. J Rheumatol. 2001; 28(3):577-80. View

Gao Q, Cheng X, Merriman T, Wang C, Cui L, Zhang H . Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study. Joint Bone Spine. 2020; 88(6):105078. DOI: 10.1016/j.jbspin.2020.09.010. View

Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T . Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2007; 67(7):960-6. PMC: 2564789. DOI: 10.1136/ard.2007.076232. View

Padang C, Muirden K, Schumacher H, Darmawan J, Nasution A . Characteristics of chronic gout in Northern Sulawesi, Indonesia. J Rheumatol. 2006; 33(9):1813-7. View

Wu E, Patel P, Mody R, Yu A, Cahill K, Tang J . Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?. J Rheumatol. 2009; 36(5):1032-40. DOI: 10.3899/jrheum.080487. View

10.

Wallace K, Riedel A, Joseph-Ridge N, Wortmann R . Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004; 31(8):1582-7. View

11.

Wang W, Krishnan E . Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham Heart Study original cohort. Rheumatology (Oxford). 2014; 54(1):91-5. DOI: 10.1093/rheumatology/keu304. View

12.

Dehlin M, Jacobsson L, Roddy E . Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020; 16(7):380-390. DOI: 10.1038/s41584-020-0441-1. View

13.

Lyu L, Hsu C, Yeh C, Lee M, Huang S, Chen C . A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr. 2003; 78(4):690-701. DOI: 10.1093/ajcn/78.4.690. View

14.

Chuang S, Lee S, Hsieh Y, Pan W . Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr. 2011; 20(2):301-8. View

15.

Lin K, Lin H, Chou P . Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol. 2000; 27(4):1045-50. View

16.

Harrold L, Yood R, Mikuls T, Andrade S, Davis J, Fuller J . Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006; 65(10):1368-72. PMC: 1798311. DOI: 10.1136/ard.2006.051649. View

17.

de Souza A, Fernandes V, Ferrari A . Female gout: clinical and laboratory features. J Rheumatol. 2005; 32(11):2186-8. View

18.

Evans P, Prior J, Belcher J, Hay C, Mallen C, Roddy E . Gender-specific risk factors for gout: a systematic review of cohort studies. Adv Rheumatol. 2019; 59(1):24. DOI: 10.1186/s42358-019-0067-7. View

19.

Vitart V, Rudan I, Hayward C, Gray N, Floyd J, Palmer C . SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40(4):437-42. DOI: 10.1038/ng.106. View

20.

Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C . Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2012; 45(2):145-54. PMC: 3663712. DOI: 10.1038/ng.2500. View